-
News | 2018.03.29
New insight into body's response to killer fungus
Scientists at the University of Aberdeen, with colleagues from several institutions, including the Institut Pasteur, have made a new discovery that could help in the fight against a fungus that kills around 200,000 people every year and causes lung and allergic diseases in millions of others.The study, carried out in collaboration with a number of institutions**, including the Institut...
-
Report | 2018.04.03
Autoimmune diseases: when our defenses turn against us
Type 1 diabetes, multiple sclerosis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, systemic lupus erythematosus, vitiligo, Crohn's disease and Guillain-Barré syndrome – these seemingly different diseases all have one thing in common: they occur when a deregulation of the immune system causes it to "attack" the organism that it is supposed to be protecting. These "autoimmune" diseases,...
-
News | 2018.03.26
Catherine Rougeot and the discovery of a new painkiller molecule
Catherine Rougeot, an Institut Pasteur guest researcher, was recognized by the Institut Pasteur in 2017 for her work in discovering a non-opioid analgesic, today called STR-324. She was appointed member of the National Academy of Inventors in the US on receiving this award. As the Institut Pasteur is celebrating its 130th anniversary this year – November 14, 2018 – let's look back at the...
-
News | 2018.04.03
Spencer Shorte appointed Chief Scientific Officer to Institut Pasteur Korea
In February 2018, Dr Spencer Shorte was named Chief Scientific Officer (CSO) to Institut Pasteur Korea.Graduated in Biochemistry from the University of Kent at Canterbury (UK) in 1988, Dr Shorte received his PhD from Bristol University in 1992. Developing live cell imaging techniques he worked through several post-doctoral fellowships in Europe and a visiting professorship in the USA before being...
-
News | 2018.03.27
Just the two of us: Holding hands can ease pain, sync brainwaves
Reach for the hand of a loved one in pain and not only will your breathing and heart rate synchronize with theirs, your brain wave patterns will couple up too, according to a new study. The study, by researchers with CU Boulder and University of Haifa, in collaboration with the Institut Pasteur published in the journal Proceedings of the National Academy of Sciences (PNAS) this week, also...
-
News | 2018.04.05
Medical entomology for surveilling vector-borne diseases explained in motion design
Pathogens transmitted by vectors insects, mosquito being the number one, are a growing threat in all parts of the world. The scientific discipline which aims to study insects impacting uman health is called medical entomology. Little known by the general public, medical entomology is nevertheless essential to identify vector insects, evaluate their risk for the health of...
-
Article | 2018.04.05
Campus
The Institut Pasteur's staff enjoy the luxury of a 5-hectare campus in the center of Paris that currently houses 39 buildings, 23 of which are used for scientific research. Several of these buildings are listed historical monuments. The Institut Pasteur has a total of 48,000m2 of laboratory space.We are fully committed to this historical campus and are currently making major investments to...
-
Article | 2018.04.05
When you arrive
We have introduced dedicated procedures for welcoming newcomers to the Institut Pasteur and helping them to settle in. As a new staff member, you will be invited to a Welcome Day shortly after you arrive, and you can also sign up for other welcome modules.
-
News | 2018.04.05
SODA, a new analysis tool for fluorescence imaging
SODA (Statistical Object Distance Analysis) is a new method for performing automatic statistical analysis on images and determining the spatial distribution of molecules. It has been made available free of charge for the scientific community via Icy and does not require any programming knowledge. This software is applicable to all fluorescence imaging and can be used for either conventional...
-
Document de presse | 2018.04.10
Hepatitis C: a novel point-of-care assay
One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus (HCV) is the diagnosis of chronic cases that are generally asymptomatic. Major progress is required for new diagnostic techniques that can be "decentralized", in other words accessed by populations and countries with limited resources. Scientists from the Institut Pasteur and Inserm, in collaboration...
